Jason D. Merker, MD, PhD

Jason D. Merker, MD, PhD

Pathologist

Bio:   Dr. Merker is a clinical laboratory-based physician who specializes in genetic disease testing for both heritable disease and cancer. He is board-certified in Molecular Genetic Pathology, Clinical Pathology, and Clinical Cytogenetics. Dr. Merker is Co-Director of the Stanford Medicine Clinical Genomics Service, a laboratory section within the Stanford Anatomic Pathology & Clinical Laboratories that uses genomic sequencing and other advanced methods to evaluate the cause of disease in patients with unexplained heritable disease. He also directs an active research group that focuses on two areas: 1) development of improved experimental and computational approaches related to the use of genomic sequencing and other “omics” assays for clinical care, and 2) identification and characterization of acquired and heritable genetic variants that are important for the development of hematologic disorders and other malignancies.

Stanford Hospital

Professional Education

  • Board Certification: Clinical Cytogenetics, American Board of Medical Genetics and Genomics (2011)
  • Board Certification: Molecular Genetic Pathology, American Board of Pathology (2011)
  • Postdoctoral Fellowship, Stanford University, Cancer Genomics (2012)
  • Fellowship, Stanford Hospital and Clinics, Clinical Cytogenetics (2010)
  • Fellowship, Stanford Hospital and Clinics, Molecular Genetic Pathology (2009)
  • Residency, Stanford Hospital and Clinics, Clinical Pathology (2008)
  • M.D., Ph.D., University of North Carolina School of Medicine, Medicine, Genetics (2005)
  • B.S., University of North Carolina, Chapel Hill, Biology (1996)
  • Board Certification, American Board of Medical Genetics, Clinical Cytogenetics (2011)
  • Board Certification, American Board of Pathology, Molecular Genetic Pathology (2011)
  • Board Certification, American Board of Pathology, Clinical Pathology (2009)

Honors & Awards

  • Phi Beta Kappa Society, University of North Carolina, Chapel Hill (1995)
  • Golden Key International Honour Society, University of North Carolina, Chapel Hill (1995)
  • Alpha Omega Alpha Honor Medical Society, University of North Carolina School of Medicine (2004)

Administrative Appointments

  • Molecular Oncology Committee Vice Chair, College of American Pathologists (2011 - 2014)
  • Molecular Oncology Committee Chair, College of American Pathologists (2015 - Present)
  • Director of Test Development in Clinical Genomics, Stanford University School of Medicine (2013 - Present)
  • Co-Director of the Stanford Medicine Clinical Genomics Service, Stanford Medicine (2013 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.